High-sensitivity troponin t as a biomarker for the development of atrial fibrillation after cardiac surgery

European Journal of Cardio-thoracic Surgery

Volumn 45, Issue 4, 2014, Pages 733-738

  Hernández romero, Diana ^a   Vílchez, Juan Antonio ^a   Lahozt, Álvaro ^a   Romero aniorte, Ana I ^a   Orenes piñero, Esteban ^a   Caballero, Luis ^a   Jara rubio, Rubén ^a   Arribas, José María ^a   García alberola, Arcadio ^a   Valdés, Mariano ^a   Lip, Gregory Y H ^b   Marín, Francisco ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Atrial fibrillation; Atrial remodelling; Cardiac surgery; HsTnT

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; TROPONIN T;

ADULT; AGED; AORTA VALVE; ARTICLE; BODY MASS; CARDIAC PATIENT; CARDIOPULMONARY BYPASS; ELECTROCARDIOGRAPHY MONITORING; EUROSCORE; FEMALE; HEART ATRIUM FIBRILLATION; HEART MUSCLE INJURY; HEART SURGERY; HUMAN; INTENSIVE CARE UNIT; ISCHEMIC HEART DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; ATRIAL FIBRILLATION; BLOOD; POSTOPERATIVE COMPLICATIONS; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR;

AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIAC SURGICAL PROCEDURES; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; TROPONIN T;

EID: 84896472639     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezt488     Document Type: Article

References (25)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV et al. Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 2001;285:2370-5.
2. Arribas-Leal JM, Pascual-Figal DA, Tornel-Osorio PL, Gutiérrez-García F, García-Puente del Corral JJ, Ray-López VG et al. Epidemiology and new predictors of atrial fibrillation after coronary surgery. Rev Esp Cardiol 2007;60:841-7.
3. Benjamín EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA 1994;271:840-4.
4. McKeown PP, Gutterman D. Executive summary: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 2005;128:1S-5S.
5. Davis EM, Packard KA, Hilleman DE. Pharmacologic prophylaxis of postoperative atrial fibrillation in patients undergoing cardiac surgery: beyond beta-blockers. Pharmacotherapy 2010;30:274-318.
6. Sánchez-Quiñones J, Marín F, Roldán V, Lip GY. The impact of statin use on atrial fibrillation. QJM 2008;101:845-61.
7. Boos C, Anderson R, Lip G. Is atrial fibrillation an inflammatory disorder? Eur Heart J 2006;27:136-49.
8. Kaireviciute D, Blann AD, Balakrishnan B, Lane DA, Patel JV, Uzdavinys G et al. Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients. Thromb Haemost 2010;104:122-7.
9. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 2000;6:513-9.
10. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009;361:858-67.
11. Panagopoulou V, Deftereos S, Kossyvakis C, Raisakis K, Giannopoulos G, Bouras G et al. NTproBNP: an important biomarker in cardiac diseases. Curr Top Med Chem 2013;13:82-94.
12. Jug B, Sebestjen M, Sabovic M, Pohar M, Keber I. Atrial fibrillation is an independent determinant of increased NT-proBNP levels in outpatients with signs and symptoms of heart failure. Wien Klin Wochenschr 2009;121:700-6.
13. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79-108.
14. Fox KF, Popescu BA, Janiszewski S, Nihoyannopoulos P, Fraser AG, Pinto FJ. Report on the European Association of Echocardiography accreditations in echocardiography: December 2003-September 2006. Eur J Echocardiogr 2007;8:74-9.
15. Gehan EA, George SL. Estimation of human body surface area from height and weight. Cancer Chemother Rep 1970;54:225-35.
16. Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999;5:816-22.
17. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third Universal Definition of Myocardial Infarction. ESC/ACCF/AHA/WHF Expert Consensus Document. Circulation 2012;126:2020-35.
18. Sato Y, Taniguchi R, Nagai K, Makiyama T, Okada H, Yamada T et al. Measurements of cardiac troponin T in patients with hypertrophic cardiomyopathy. Heart 2003;89:659e60.
19. Hudson MP, O'Connor CM, Gattis WA, Tasissa G, Hasselblad V, Holleman CM et al. Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis. Am Heart J 2004;147:546e52.
20. Moreno V, Hernández-Romero D, Vilchez JA, García-Honrubia A, Cambronero F, Casas T et al. Serum levels of high-sensitivity troponin T: a novel marker for cardiac remodeling in hypertrophic cardiomyopathy. J Card Fail 2010;16:950-6.
21. Omland T, Pfeffer MA, Solomon SD, de Lemos JA, Røsjø H, Saltyt Benth J et al. PEACE Investigators. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol 2013;61:1240-9.
22. Korley FK, Jaffe AS. Preparing the United States for High-Sensitivity Cardiac Troponin Assays. J Am Coll Cardiol 2013;61:1753-8.
23. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiov Res 2002;54:230-46.
24. Liang Y, Wang S, Gu M. Is NT-pro-BNP predictive of atrial fibrillation in patients undergoing coronary artery bypass surgery? Eur J Cardiothorac Surg 2010;38:389-90.
25. Roldán V, Marín F, Díaz J, Gallego P, Jover E, Romera M et al. High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation. J Thromb Haemost 2012;10:1500-7.